Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-10858357-B2 · Dec 8, 2020 · US
This page is not indexed by search engines while we improve data quality.
Printnet Ltd — Human Necessities
Printnet Ltd holds 2 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Printnet Ltd |
| Technology | Human Necessities |
| Patents in slice | 2 |
| Recent patents in slice | 0 |
| First year | 2019 |
| Last year | 2020 |
Representative patents
Notable publications linking Printnet Ltd to Human Necessities.
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-10858357-B2 · Dec 8, 2020 · US
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-10858357-B2 · Dec 8, 2020 · US
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-2019084979-A1 · Mar 21, 2019 · US
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-2019084979-A1 · Mar 21, 2019 · US
Recent filings
Latest patents from Printnet Ltd in Human Necessities.
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-10858357-B2 · Dec 8, 2020 · US
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-10858357-B2 · Dec 8, 2020 · US
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-10858357-B2 · Dec 8, 2020 · US
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-2019084979-A1 · Mar 21, 2019 · US
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
US-2019084979-A1 · Mar 21, 2019 · US
Related pages
Navigate to parent entity pages.